BIBX 1382 - CAS# 196612-93-8 Size:Solid 2 mg Gamache DA

Gamache DA

It is being studied for various clinical indications and in some cases it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner") since it does not require blood tests for international normalized ratio (INR) monitoring while offering similar results in terms of efficacy

which are both essential for bacterial viability

Chemical Name: (3S)-3-(4-{[4'-(trifluoromethyl)-[1

BIBX 1382 - CAS# 196612-93-8 Size:Solid 2 mg Gamache DAFalnidamol, also known as BIBX 1382, is a pyrimido pyrimidine with antitumor activity. BIBX 1382 inhibits the intracellular tyrosine kinase domain of the Epidermal Growth Factor Receptor (EGFR) thus specifically reversing the aberrant enzymatic activity from overexpressed and constitutively activated EGFR, and subsequently inhibiting cell proliferation and inducing cell differentiation. Check for active clinical trials or closed clinical trials using